Latest Debt News

Page 11 of 511
LTR Pharma is shifting gears from clinical trials to commercial rollout, securing US partnerships for ROXUS and reporting encouraging SPONTAN Phase II data that supports FDA approval ambitions.
Ada Torres
Ada Torres
28 Aug 2026
St Barbara Limited's FY26 statutory profit surged to A$490 million, driven by a A$500 million gain from deconsolidating New Simberi Gold after Lingbao's strategic investment. The company declared a fully franked dividend and is weighing a significant share buy-back while advancing key gold projects.
Maxwell Dee
Maxwell Dee
28 Aug 2026
Swift TV Ltd advanced its commercial rollout with 7,190 devices sold and secured key technology certifications in FY26, while navigating a 22% revenue decline due to legacy contract wind-downs. The company delivered positive EBITDA and raised $2.3 million to fund growth initiatives.
Sophie Babbage
Sophie Babbage
28 Aug 2026
Shine Justice Ltd reported a modest 2.3% revenue increase to $209.2 million for FY26, alongside a striking 1,578% jump in net profit after tax to $9.6 million. The company declared a fully franked final dividend of 2.5 cents per share, signalling confidence amid ongoing investments in technology and international expansion.
Victor Sage
Victor Sage
28 Aug 2026
Air New Zealand reported a $242 million net loss for FY2026, hit by soaring fuel prices and multi-year engine issues despite revenue growth and operational gains.
Victor Sage
Victor Sage
28 Aug 2026
McMillan Shakespeare (ASX:MMS) reported a 13.8% rise in underlying net profit after tax and amortisation to $107.9 million for FY26, driven by strong novated lease growth and accelerating electric vehicle adoption.
Claire Turing
Claire Turing
28 Aug 2026
Echelon Resources (ASX:ECH) reported a 341% jump in net profit to A$28.2 million for FY26, driven by stronger gas prices and a A$12.1 million gain from its exit of Cue Energy. The group also repaid A$37 million of debt, leaving it well positioned for upcoming gas drilling at Palm Valley.
Maxwell Dee
Maxwell Dee
28 Aug 2026
Rua Bioscience's FY26 results highlight a 71% surge in customer revenue driven by international expansion, yet the company continues to face significant losses and going concern risks.
Victor Sage
Victor Sage
28 Aug 2026
Locate Technologies (NZX: LOC) posted a NZD 3.53 million loss for FY2026 despite 7.8% revenue growth, facing refinancing uncertainty on a major debt facility due in November.
Sophie Babbage
Sophie Babbage
28 Aug 2026
Delegat Group (NZX:DGL) reported a 20% jump in operating NPAT to NZD 61.5 million for FY26, driven by record EBITDA and a 4% rise in global case sales. The Board declared a 22-cent dividend, up 10%, while net debt fell by NZD 51.8 million.
Victor Sage
Victor Sage
28 Aug 2026
Air New Zealand reported a $242 million net loss after tax for FY2026, hit by soaring fuel costs linked to the Middle East conflict and persistent engine issues. The airline unveiled a new strategy aiming for operational resilience and targeted growth amid ongoing cost pressures.
Victor Sage
Victor Sage
28 Aug 2026
Comvita Limited has swung back to profitability in FY26, reporting $7.7 million net profit after a $40.5 million capital raise that brought Southeast Asian consumer giant F&N Ventures on board with a near 20% stake.
Victor Sage
Victor Sage
28 Aug 2026

Browse the archive

Full archive